---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-083444"
form_type: "8-K"
ticker: "ENGN"
cik: "0001980845"
company_name: "enGene Therapeutics Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:35:38.880360+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# enGene signs 5-year lease for 26,335 sq ft Boston office; parent guarantees rent

## Summary
- Lease with 99 High Street Owner LLC for office at 99 High Street, Boston, MA (26,335 rentable square feet).
- Initial term of 5 years 5 months, starting ~June 19, 2025; rent abated for first 5 months.
- Monthly base rent starts at ~$168,982 (Year 1) and escalates to ~$182,912 (Year 5), plus operating expenses and taxes.
- Parent enGene Holdings Inc. executed an unconditional guaranty of all Tenant obligations under the Lease.
- Rentable area is 3.60% of Building; base year for operating expenses is 2026, taxes fiscal year 2026.

## SEC filing metadata
- accession: 0000950170-25-083444
- form_type: 8-K
- ticker: ENGN
- cik: 0001980845
- company_name: enGene Therapeutics Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1980845/000095017025083444/0000950170-25-083444-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1980845/000095017025083444/engn-20250604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-083444
- JSON: https://secwatch.observer/filing/0000950170-25-083444.json
- Plain text: https://secwatch.observer/filing/0000950170-25-083444.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.